Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Regulatory Approval

360 One Wam Regulatory Approval

360 ONE Distribution Services' IFSC branch, a subsidiary of 360 ONE WAM, received an IFSCA Certificate of Registration to act as broker dealer, clearing member, depository participant, research entity and distributor. This is a regulatory licence authorising new activities in the IFSC.

Source

BSE filing, NSE: 360ONE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

360 One Wam Ltd: key numbers

Share price
₹985.00
Market cap
₹42,245 Cr
Revenue (annual)
₹4,362 Cr
Net profit (annual)
₹1,216 Cr
P/E (TTM)
33.9×Sector 19.8×
Promoter holding
5.88%-0.32% QoQ
FII holding
56.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from 360 One Wam Ltd

All →

Other regulatory approval announcements

All →
12:15 IST NSE
Regulatory ApprovalAGI Infra Ltd AGIIL

AGI Infra Regulatory Approval

Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.

Execution
Valid up to March 30, 2031
21:58 IST BSE
Regulatory ApprovalNesco Ltd NESCO

Nesco Regulatory Approval

Nesco Limited received a Commencement Certificate from BMC for Tower-2 and Hall-1 at Nesco Center, Goregaon. The company can now proceed with construction and development of the proposed projects, valid until 29 October 2027.

19:10 IST NSE
Regulatory ApprovalGrasim Industries Ltd GRASIM

Grasim Industries Regulatory Approval

CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.

08:07 IST BSE
Regulatory ApprovalHikal Ltd HIKAL

Hikal Regulatory Approval

Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.

08:05 IST BSE
Regulatory ApprovalSun Pharmaceutical Industries Ltd SUNPHARMA

Sun Pharmaceutical Industries Regulatory Approval

Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.